NZ: Fonterra fined for delayed botulism disclosure
Fonterra has been fined NZ$150m for the delay in disclosing information about the botulism scare
Fonterra has agreed to fork out NZ$150,000 (US$129,700) in settlement costs over the delayed disclosure of the botulism scare last year.
The dairy firm said today (13 June) it "reached a settlement with NZX in relation to the continuous disclosure of information during the precautionary whey protein concentrate (WPC80) recall in August 2013".
"As part of a full and final settlement, we have acknowledged the Tribunal's views and agreed to make a payment of $150,000," said group director governance and legal Mike Cronin.
"Following the Fonterra Board's Independent Inquiry into WPC80, and as the Tribunal's statement sets out, Fonterra has made significant changes to ensure improved identification, management and escalation of emerging risks across the Co-operative, with a particular focus on food safety and quality," he added.
Fonterra is also facing legal action from French diary giant Danone, which is attempting to recoup its losses associated with the recall. Danone has estimated the recall resulted in lost sales of EURE350m (US$476m).
Danone’s strategic direction in 2014 remained very similar to the strategy adopted the previous year, which was based on launching new products, new formats and new flavours, in order to attract consu...
Danone-Productie si Distributie de Produse Alimentare (PDPA)’s main strategy in Romania consists of attracting consumers with affordable prices, promotions and new product launches. Approximately 90% ...
- Why Jet.com purchase could boost Wal-Mart online
- Murray Goulburn's FY results - 7 things to learn
- Nestle on China, candy, nutrition - analysis
- Interview, part 1: Emmi CEO Urs Riedener
- England child obesity plan should cheer industry
- Mondelez buys rest of Vietnam snacks business
- Australia launches dairy sector probe
- Tyson faces investor scrutiny on ethical issues
- Nomad Foods touts progress as H1 results worsen
- Mengniu grows sales but net profit slips